Merle M. Krebber

467 citations
17 papers · 279 indexed · h-index 10

Merle M. Krebber

14 papers receiving 278 citations

Peers

Merle M. Krebber
Comparison fields: 5 of 69
  • Transplantation 31
  • Biomaterials 56
  • Nephrology 30
  • Cardiology and Cardiovascular Medicine 58
  • Biomedical Engineering 82
Replace Catherine Y. Wang with:
Catherine Y. Wang United States
Virginie Joris Belgium
Naima Banouni United States
Zexu Dang United Kingdom
Maria Elena Melica Italy
Yuka Matsuura Japan
Parisa Ranjzad United Kingdom
Haige Zhao China
Liangqing Hong China
Merle M. Krebber relative to Catherine Y. Wang United States Catherine Y. Wang's profile →
Citations per field
00.5×3.8×
Catherine Y. Wang · 1×
Citations per year

Countries citing papers authored by Merle M. Krebber

Since Specialization
Citations

This map shows the geographic impact of Merle M. Krebber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merle M. Krebber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merle M. Krebber more than expected).

Fields of papers citing papers by Merle M. Krebber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merle M. Krebber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merle M. Krebber. The network helps show where Merle M. Krebber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Merle M. Krebber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Merle M. Krebber Line = papers co-authored together Merle M. Krebber links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20252
2 20250
3 20250
4 20250
5 202412
6 20233
7 20231
8 202119
9 202134
10 202122
11 202041
12 202062
13 201919
14 20189
15 20187
16 201634
17 201514

About Merle M. Krebber

Merle M. Krebber is a scholar working on Transplantation, Nephrology and Biomaterials, having authored 17 papers that have together received 279 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (3 papers), Cardiovascular Function and Risk Factors (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Infectious Aortic and Vascular Conditions (2 papers), Heart Failure Treatment and Management (2 papers), Diabetes Treatment and Management (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Transplantation (31 citations), Biomaterials (56 citations) and Nephrology (30 citations). Merle M. Krebber has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Marianne C. Verhaar, Caroline Cheng, Dirk J. Duncker, Maarten M. Brandt, Chris Van Dijk, Henny G. Otten, Carlijn V. C. Bouten, Anthal I.P.M. Smits, Jaap A. Joles and Joost O. Fledderus. Their work appears in journals such as Journal of Clinical Investigation, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026